On October 29, 2024, Parkinson Canada headed to Ottawa alongside people living with Parkinson’s for a full day of discussion … Read More
The price tag of Parkinson’s could reach $4.4B by 2034
New report highlights financial toll of Parkinson’s on individuals, care partners and the Canadian health care system Toronto, ON—Oct 8, … Read More
GBA1 Meeting 2024 Summary
Parkinson Canada had the pleasure of sponsoring and attending the first ever international meeting focused on GBA1. Held at the … Read More
Improved Parkinson’s Care in New Brunswick
James Caldwell, Lead of Government Relations and Atlantic Relationships at Parkinson Canada meets with CBC Radio to discuss the availability … Read More
Living well with Parkinson’s is possible – Parkinson Canada marks Parkinson’s Awareness Month in April
TORONTO, ON (April 2, 2024) – Parkinson’s is a lifelong, incurable brain disease and no two experiences are alike. Each … Read More
Canadian Open Parkinson Network opens new Halifax site
HALIFAX, NS (MARCH 27, 2024) – Good science is made possible only by good data. That’s why Parkinson Canada is … Read More
VYALEV (foslevodopa/foscarbidopa solution) is now available in Canada
A new treatment option for advanced Parkinson’s disease is now available called VYALEV. This treatment is the first and only … Read More
Parkinson Canada Welcomes Progress on Pharmacare Accessibility
Toronto, February 29, 2024 – Today, the Government of Canada tabled its much-anticipated pharmacare plan. The legislation, if passed, will … Read More
APO-go® PEN is available in Canada
Apomorphine hydrochloride is a critical medication for the management of hypomobility. It is used to help with “off” episodes in … Read More
2023 – a year of progress and hope
2023 has been a busy year for us at Parkinson Canada. We’ve been hard at work making sure the needs … Read More